Cost-effectiveness analysis of ribociclib versus...

Cost-effectiveness analysis of ribociclib versus palbociclib in the first-line treatment of HR+/HER2– advanced or metastatic breast cancer in Spain

Galve-Calvo, Elena, González-Haba, Eva, Gostkorzewicz, Joana, Martínez, Irene, Pérez-Mitru, Alejandro
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
Volume 10
Language:
english
Journal:
ClinicoEconomics and Outcomes Research
DOI:
10.2147/CEOR.S178934
Date:
November, 2018
File:
PDF, 2.67 MB
english, 2018
Conversion to is in progress
Conversion to is failed